Roche to buy Ignyta for $1.7 billion

2nd January 2018 Uncategorised 0

Roche has announced plans to buy US group Ignyta for $27 a share in an all-cash deal totaling around $1.7 billion, securing itself access to the latter’s experimental cancer medicines.

More: Roche to buy Ignyta for .7 billion
Source: News